MOLECULAR BIOLOGY OF OSTEOARTHRITIS & CHONDRODYSPLASIAS

骨关节炎的分子生物学

• 批准号: 3085675
• 负责人: PAUL KATZENSTEIN
• 金额: $ 9.38万
• 依托单位: UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON
• 依托单位国家: 美国
• 财政年份: 1991
• 资助国家: 美国
• 起止时间: 1991-09-18 至 1996-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3085675
• 关键词: achondroplasia; alleles; articular cartilage; cartilage development; cartilage disorder; cartilage metabolism; collagen; disease /disorder model; electron microscopy; endonuclease; gene expression; gene mutation; genetic manipulation; genetically modified animals; immunoelectron microscopy; in situ hybridization; laboratory mouse; model design /development; molecular cloning; northern blottings; nucleic acid sequence; osteoarthritis; phenotype; polymerase chain reaction; protein structure function; proteoglycan; radiography; restriction mapping; tissue /cell culture

This Physician Scientist Award proposal is designed to permit the candidate to acquire basic and advanced knowledge and skills in molecular biologic investigation and to apply these to the study of cartilage diseases. Graduate coursework in cell and molecular biology and protein biochemistry which provide a firm basis for future research endeavors will be taken during the first year of this Award. During Phase I, transgenic mouse models of human disease, containing mutations in the alpha2 chain of type IX collagen, will be generated. Type IX collagen Is a cartilage-specific molecule with unique structural features that likely render the molecule necessary for normal cartilage structure and function. Because mutations in type II collagen have been shown to cause human disease, it is quite likely that abnormalities of type IX collagen do also. Three or four mutations in the alpha2 (IX) chain, which contains interchain disulfide bridges, crosslink sites to type II collagen, a glycosaminoglycan attachment site and a kink region, will be constructed and transgenic mice containing these mutations generated. Abnormal phenotypes will be characterized radiographically and microscopically. During Phase II, mechanisms by which these mutations alter normal development, structure and function of cartilage will be sought. At the same time, information on the structure-function relationship of various domains of the type IX molecule will be obtained. This phase of the Award will prepare the candidate for additional studies of the molecular genetics of human cartilage diseases.

这项医师科学家奖提案旨在允许候选人 掌握分子生物学的基本和高级知识和技能 并将其应用于软骨疾病的研究。 细胞与分子生物学和蛋白质生物化学研究生课程 将为未来的研究努力提供坚实的基础 在该奖项的第一年。 在第一阶段，人类疾病的转基因小鼠模型，包括 将产生IX型胶原蛋白的α2链突变。类型 IX胶原蛋白是一种软骨特异性分子，具有独特的结构 可能导致正常软骨所需的分子的特征 结构和功能。因为II型胶原的突变已经被 被证明会导致人类疾病，很可能是类型的异常 九号胶原蛋白也是如此。Alpha2(IX)链中的三到四个突变， 它含有链间二硫键，与类型II的交联点 胶原蛋白，一个糖胺多糖的附着部位和一个扭结区域，将是 构建并产生了含有这些突变的转基因小鼠。 异常的表型将被放射学表征和 显微镜下看。 在第二阶段，这些突变改变正常的机制 将探索软骨的发展、结构和功能。在 同时，各种结构-功能关系的信息 将获得IX型分子的结构域。这一阶段的奖项 将为分子遗传学的进一步研究做好准备 人类软骨疾病。